Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
0.263
+0.004 (1.55%)
At close: Nov 4, 2024, 4:00 PM
0.256
-0.007 (-2.62%)
Pre-market: Nov 5, 2024, 5:32 AM EST
Lyra Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -101.39 | -62.68 | -55.28 | -43.51 | -22.13 | -16.31 | |
| Depreciation & Amortization | 0.3 | 0.28 | 1.07 | 1 | 0.1 | 0.03 | |
| Loss (Gain) From Sale of Assets | - | - | - | - | -0.05 | - | |
| Asset Writedown & Restructuring Costs | 24.72 | 1.59 | 1.32 | - | - | - | |
| Loss (Gain) From Sale of Investments | -3.75 | -3.5 | -0.49 | - | - | - | |
| Stock-Based Compensation | 6.21 | 5.89 | 5.45 | 2.77 | 1.81 | 0.24 | |
| Provision & Write-off of Bad Debts | - | - | - | - | - | 0.17 | |
| Change in Accounts Payable | -0.92 | 0.45 | -2.41 | 2.35 | 0.35 | -0.21 | |
| Change in Unearned Revenue | -1.82 | -1.56 | 3.64 | 11.72 | - | - | |
| Change in Other Net Operating Assets | 0.91 | -3.78 | 3.33 | -0.14 | -1.22 | 2.32 | |
| Operating Cash Flow | -75.61 | -63.3 | -43.39 | -25.82 | -21.14 | -13.75 | |
| Capital Expenditures | -3.28 | -1.05 | -0.16 | -3.39 | -1.78 | -0.21 | |
| Investment in Securities | 29.97 | -11.54 | -64.84 | - | - | - | |
| Investing Cash Flow | 26.7 | -12.58 | -65.01 | -3.39 | -1.78 | -0.21 | |
| Issuance of Common Stock | 28.07 | 69.35 | 100.5 | 0.6 | 59.9 | 0.11 | |
| Other Financing Activities | -1.01 | -3.65 | -4.25 | -0.25 | -2.59 | -0.23 | |
| Financing Cash Flow | 27.06 | 65.69 | 96.26 | 0.36 | 87.7 | -0.12 | |
| Net Cash Flow | -21.86 | -10.2 | -12.13 | -28.85 | 64.79 | -14.08 | |
| Free Cash Flow | -78.88 | -64.35 | -43.55 | -29.21 | -22.92 | -13.97 | |
| Free Cash Flow Margin | -4334.29% | -4130.36% | -3195.08% | -10247.37% | - | - | |
| Free Cash Flow Per Share | -1.27 | -1.29 | -1.44 | -2.25 | -2.67 | -69.10 | |
| Levered Free Cash Flow | -40.52 | -33.73 | -33.03 | -14.45 | -15.17 | -7.19 | |
| Unlevered Free Cash Flow | -40.66 | -33.73 | -33.03 | -14.45 | -15.17 | -7.19 | |
| Change in Net Working Capital | -2.75 | -2.11 | 5.02 | -12.43 | 1.42 | -3.08 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.